NR4A1 and breast cancer: Tamoxifen is a well-established selective estrogen receptor modulator (SERM) that exhibits both antagonistic and agonistic estrogen signaling in different parts of the body, but mainly functions as an antagonist to present antitumor effects against hormone receptor-positive BC cells [89].